Fred Upton actually said...
When we first launched the 21st Century Cures initiative in April, we had a pretty good idea that learning about the benefits and risks of a drug or device doesn't end when FDA initially approves or clears the product for use in certain patients with a specific disease or set of conditions.
Context
Upton discusses the ongoing evaluation of drug and device benefits post-approval.
07/21/2014